These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3545749)

  • 41. Hematopoietic growth factors in breast cancer--overview.
    Osborne CK
    Breast Cancer Res Treat; 1991 Dec; 20 Suppl():S1-2. PubMed ID: 1806028
    [No Abstract]   [Full Text] [Related]  

  • 42. Novel combinations for treating metastatic breast cancer: improving the odds. Introduction.
    Schwartz J; Wong ST
    Am J Health Syst Pharm; 2009 Dec; 66(23 Suppl 6):S1-2. PubMed ID: 19923315
    [No Abstract]   [Full Text] [Related]  

  • 43. The search for an elusive uniform strategy for a heterogeneous disease: lesson learned?
    Seidman AD
    J Clin Oncol; 2013 May; 31(14):1707-8. PubMed ID: 23569322
    [No Abstract]   [Full Text] [Related]  

  • 44. Patterns of care studies in oncology: considerable potential utility, but risk of serious bias.
    Markman M
    Oncology; 2011; 81(3-4):158-9. PubMed ID: 22041922
    [No Abstract]   [Full Text] [Related]  

  • 45. The new math of clinical trials.
    Couzin J
    Science; 2004 Feb; 303(5659):784-6. PubMed ID: 14764863
    [No Abstract]   [Full Text] [Related]  

  • 46. Cardiotoxicity due to chemotherapy for breast cancer: the dark side of the moon.
    Peruzzi M; Palazzoni G; Biondi-Zoccai G; Lotrionte M
    Anatol J Cardiol; 2015 Jan; 15(1):61-2. PubMed ID: 25550249
    [No Abstract]   [Full Text] [Related]  

  • 47. Treatment of early breast cancer.
    Price LA; Hill BT
    Lancet; 1984 Dec; 2(8417-8418):1461. PubMed ID: 6151064
    [No Abstract]   [Full Text] [Related]  

  • 48. Reversible nail loss after cancer chemotherapy.
    Kumar L; Kochupillai V
    Acta Oncol; 1990; 29(4):471. PubMed ID: 2390273
    [No Abstract]   [Full Text] [Related]  

  • 49. Enhancing therapeutic decision making when options abound: toxicities matter.
    Kuderer NM; Wolff AC
    J Clin Oncol; 2014 Jul; 32(19):1990-3. PubMed ID: 24868027
    [No Abstract]   [Full Text] [Related]  

  • 50. Drugs that lack single-agent activity: are they worth pursuing in combination?
    Gyawali B; Prasad V
    Nat Rev Clin Oncol; 2017 Apr; 14(4):193-194. PubMed ID: 28266519
    [No Abstract]   [Full Text] [Related]  

  • 51. PRESsed for time.
    Afsar-Manesh N; El-Farra N; Billings M; Lazarus M
    J Hosp Med; 2009 May; 4(5):321-2. PubMed ID: 19504548
    [No Abstract]   [Full Text] [Related]  

  • 52. The 2011 EBCTCG polychemotherapy overview.
    Palmieri C; Jones A
    Lancet; 2012 Feb; 379(9814):390-2. PubMed ID: 22152852
    [No Abstract]   [Full Text] [Related]  

  • 53. Nanomedicine for Combination Therapy of Cancer.
    He C; Chan C; Weichselbaum RR; Fleming GF; Yamada SD; Lin W
    EBioMedicine; 2015 May; 2(5):366-7. PubMed ID: 26137577
    [No Abstract]   [Full Text] [Related]  

  • 54. Design of forms for clinical trials.
    Benson EA
    Br Med J; 1979 Sep; 2(6192):738-9. PubMed ID: 509103
    [No Abstract]   [Full Text] [Related]  

  • 55. No relevant influence on overall survival time in patients with metastatic breast cancer undergoing combination chemotherapy.
    Petru E; Schmähl D
    J Cancer Res Clin Oncol; 1988; 114(2):183-5. PubMed ID: 3350851
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anticancer activity of bisphosphonic acids in methylnitrosourea-induced mammary carcinoma of the rat--benefit of combining bisphosphonates with cytostatic agents.
    Wingen F; Pool BL; Klein P; Klenner T; Schmähl D
    Invest New Drugs; 1988 Sep; 6(3):155-67. PubMed ID: 3056867
    [TBL] [Abstract][Full Text] [Related]  

  • 57. On the role of additive hormone monotherapy with tamoxifen, medroxyprogesterone acetate and aminoglutethimide, in advanced breast cancer.
    Petru E; Schmähl D
    Klin Wochenschr; 1987 Oct; 65(20):959-66. PubMed ID: 2963170
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modulation of cytosolic sexual steroid receptors in autochthonous methylnitrosourea-induced rat mammary carcinoma following application of 2-chloroethylnitrosocarbamoyl-L-alanine linked to oestradiol or dihydrotestosterone.
    Corr R; Berger MR; Betsch B; Floride JA; Brix HP; Schmähl D
    Br J Cancer; 1990 Jul; 62(1):42-7. PubMed ID: 2390481
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Janus-faced character of chemotherapy: a comment on the Abel theses].
    Schmähl D
    Klin Wochenschr; 1991 Jan; 69(1):49-51. PubMed ID: 2016847
    [No Abstract]   [Full Text] [Related]  

  • 60. [Importance of the composition of various combination regimens in the chemotherapy of metastatic breast cancer].
    Petru E; Schmähl D
    Dtsch Med Wochenschr; 1987 Feb; 112(7):270-5. PubMed ID: 3545749
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.